Human lipoproteins comprise at least 12 different classes that are lognormally distributed

Tomokazu Konishi; Risako Fujiwara; Tadaaki Saito; Nozomi Satou; Naoko Crofts; Ikuko Iwasaki; Yoshihisa Abe; Shinpei Kawata; Tatsuya Ishikawa

doi:10.1101/2021.03.19.21253934

Summary

Lipoproteins in medical samples have been measured by enzymatic methods that coincide with conventional ultracentrifugation. However, the high gravity and time required for ultracentrifugation can cause sample degradation. This study presents the results of HPLC, a gentler and rapid separation method, for 55 human serum samples. The elution patterns were analysed parametrically, and the attribute of each class was confirmed biochemically. Human samples contained 12 classes of lipoproteins, each of which may consist primarily of proteins. There are three classes of VLDLs. The level of each class was distributed lognormally, and the standard amount and the 95% range were estimated. Enzymatic methods measure the levels of several mixed classes. This lognormal character suggests that the levels are controlled by the synergy of multiple factors.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Funding Statement

This study is supported by the scholarship donation of Akita Prefectural University.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethics committee of Akita Cerebrospinal and Cardiovascular Center (ID. 19-21, 2018/5/7)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

I am so sorry but I mistakenly added "1" in the title. This was removed.

Data Availability

All the data is available at Figshare https://doi.org/10.6084/m9.figshare.14247119.v1

https://doi.org/10.6084/m9.figshare.14247119.v1

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.